Stock Report

Download full stock data and analysis for free Last Updated: 08-Sep-2026

Stock Rating

Is this stock worth it? Our ratings reveal the truth.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

NGM Biopharmaceuticals (NGM) Key Ratios

Stock Card factsheet share-fund-plan-icon

$1.54

$0.00 (0.00%)

As on 08-Apr-2024 09:30EDT

Market cap

info icon

$129 Mln

Revenue (TTM)

info icon

$4 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

0.9

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -71.65 -99.09 -92.02 -63.02 -47.30
EBIT 4.41 23.77 8.86 -17.72 -301.54
Net Profit 3.91 19.98 12.10 -14.02 -408.98
EPS 2.74 21.93 14.91 -4.54 -277.40
Book Value -- -- -44.13 -23.93 -43.38
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-23Dec-22Dec-21
EBIT-Margin info -1,257.74-787.94-3,317.79-300.45-154.97
Net Margin info -146.26-94.05-----146.26
Return on equity info -53.40-40.40-69.76-53.46-36.98
Return on Capital info -52.43-39.81-68.85-52.07-36.36
Return on Assets info -45.25-34.27-59.79-44.83-31.12
Debt to Equity (x) info ------0.020.03

Profitability

View Detailed Peer Comparison

ROCE

-68.85

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
-68.85
-52.07
-36.36
-30.78
-11.01
Peer Median
--
--
--
--
--
ROE

-69.76

--

Profit after tax / Average Net worth * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
-69.76
-53.46
-36.98
-30.78
-11.01
Peer Median
--
--
--
--
--
ROA

-59.79

--

Profit after tax / Average Total assets * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
-59.79
-44.83
-31.12
-26.50
-9.10
Peer Median
--
--
--
--
--
EBIT Margin

-3,317.79

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
-3,317.79
-300.45
-154.97
-118.85
-47.65
Peer Median
--
--
--
--
--
Net Margin

-3,223.34

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
-3,223.34
-287.50
-146.26
-108.32
-27.56
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

-0.92

--

Year on year growth in net sales

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
-0.92
-0.29
-0.11
-0.16
-0.05
Peer Median
--
--
--
--
--
EBIT Growth

11.85

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
11.85
-37.74
-16.24
-110.44
-1,043.72
Peer Median
--
--
--
--
--
Net Profit Growth

10.50

--

Year on year growth in profit after tax

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
10.50
-39.76
-21.10
-229.82
-5,680.53
Peer Median
--
--
--
--
--
EPS Growth

0.13

--

Year on year growth in earnings per share

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
0.13
-0.35
-0.07
-1.43
-5.94
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

--

--

Total debt / Net worth

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
--
0.02
0.03
--
--
Peer Median
--
--
--
--
--
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
--
0.02
0.02
--
--
Peer Median
--
--
--
--
--
Current Ratio

7.79

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
7.79
6.04
6.18
7.24
8.94
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
--
6.04
6.18
7.24
8.94
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
--
-44.76
-18.72
-53.55
--
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

1.31

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
1.31
13.70
6.35
7.36
5.03
Peer Median
--
--
--
--
--
Asset Turnover

0.02

--

Sales / Average Total Assets

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
0.02
0.16
0.21
0.25
0.33
Peer Median
--
--
--
--
--
Receivable days

315.80

--

Average Debtors / Sales * 365

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
315.80
41.34
26.68
24.33
15.65
Peer Median
--
--
--
--
--
Inventory Days

0.00

--

Average Inventory / Sales * 365

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
0.00
0.00
0.00
0.00
0.00
Peer Median
--
--
--
--
--
Payable days

940.26

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
940.26
418.08
344.70
20.82
43.42
Peer Median
--
--
--
--
--
Cash Conversion Cycle

-624.46

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
-624.46
-376.74
-318.02
3.51
-27.76
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

-0.49

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
-0.49
-2.52
-11.98
-21.92
-32.44
Peer Median
--
--
--
--
--
Price / Book Value

0.47

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
0.47
1.55
4.06
7.36
2.80
Peer Median
--
--
--
--
--
EV/EBITDA

0.53

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-23
Dec-22
Dec-21
Dec-20
Dec-19
NGM Biopharmaceuticals (NGM)
0.53
-0.84
-8.79
-18.14
-13.90
Peer Median
--
--
--
--
--
loading...
loading...